Related references
Note: Only part of the references are listed.Glycated albumin is stable in plasma when exposed to common laboratory conditions and comparable when drawn from venous or capillary sites
Andrew N. Reynolds et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)
Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study
Molly Jung et al.
JOURNAL OF DIABETES (2018)
Clinical usefulness of Glycated Albumin in the diagnosis of diabetes: Results from an Italian study
Chiara Bellia et al.
CLINICAL BIOCHEMISTRY (2018)
Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol
Elizabeth Selvin et al.
CLINICAL CHEMISTRY (2018)
Interpretation of HbA(1c) in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory (CopLab) Database
R. Borg et al.
DIABETIC MEDICINE (2018)
Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study
Junichi Hoshino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Anemia modifies the prognostic value of glycated hemoglobin in patients with diabetic chronic kidney disease
I-Ching Kuo et al.
PLOS ONE (2018)
Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients With Diabetes and CKD
Ting Gan et al.
KIDNEY INTERNATIONAL REPORTS (2018)
Editor's Choice - Impact of initial hospital diagnosis on mortality for acute myocardial infarction: A national cohort study
Jianhua Wu et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2018)
Definition of the upper reference limit of glycated albumin in blood donors from Italy
Chiara Bellia et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis
Christina W. Chen et al.
CLINICAL CHEMISTRY (2017)
Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study
Luisa Agnello et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2017)
Glycated albumin: from biochemistry and laboratory medicine to clinical practice
Elena Dozio et al.
ENDOCRINE (2017)
Serum Glycated Albumin to Guide the Diagnosis of Diabetes Mellitus
Wan-Chen Wu et al.
PLOS ONE (2016)
Body mass index negatively regulates glycated albumin through insulin secretion in patients with type 2 diabetes mellitus
Masafumi Koga et al.
CLINICA CHIMICA ACTA (2015)
GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS
Cyrus V. Desouza et al.
ENDOCRINE PRACTICE (2015)
Glycated albumin as a diagnostic tool for diabetes in a general Japanese population
Hiroaki Ikezaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Glycated albumin is a more accurate glycaemic indicator than haemoglobin A1c in diabetic patients with pre-dialysis chronic kidney disease
Il Young Kim et al.
NEPHROLOGY (2015)
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
Lesley A. Inker et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
John M. Lachin et al.
DIABETES CARE (2014)
Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the UK National Diabetes Audit
C. J. Hill et al.
DIABETIC MEDICINE (2014)
Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?
Marijn Speeckaert et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
The Relationship between BMI and Glycated Albumin to Glycated Hemoglobin (GA/A1c) Ratio According to Glucose Tolerance Status
Ji Hye Huh et al.
PLOS ONE (2014)
Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects
Martina Montagnana et al.
CLINICA CHIMICA ACTA (2013)
Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment
J. Konya et al.
DIABETIC MEDICINE (2013)
Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes A 6-Year Cohort Study
Joni Ricks et al.
DIABETES (2012)
Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments
H. K. Won et al.
DIABETIC MEDICINE (2012)
Low Plasma Albumin Levels Are Associated with Increased Plasma Protein Glycation and HbA1c in Diabetes
Hemangi S. Bhonsle et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients
Eun Young Lee et al.
ACTA DIABETOLOGICA (2011)
Determining Stability of Stored Samples Retrospectively: The Validation of Glycated Albumin
David M. Nathan et al.
CLINICAL CHEMISTRY (2011)
Glycemic Control and Survival in Peritoneal Dialysis Patients with Diabetes Mellitus
Uyen Duong et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Target for Glycemic Control in Type 2 Diabetic Patients on Hemodialysis: Effects of Anemia and Erythropoietin Injection on Hemoglobin A1c
Takashi Uzu et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2009)
Review of hemoglobin A(1c) in the management of diabetes
Emily Jane Gallagher et al.
JOURNAL OF DIABETES (2009)
Chronic kidney disease and mortality risk: A systematic review
Marcello Tonelli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis
I El-Agouza et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2002)
Defining the relationship between plasma glucose and HbA1c -: Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial
CL Rohlfing et al.
DIABETES CARE (2002)
Share Paper
